Generate Biomedicines, Inc. (GENB) on Thursday priced its initial public offering of 25,000,000 shares of stock at $16 per share, raising gross proceeds of $400 million.
The offering is expected to close on March 2.
The company granted underwriters a 30-day option to purchase up to an additional 3,750,000 shares at the initial public offering price.
The company said that the shares are expected to begin trading on the Nasdaq Global Select Market on February 27 under the ticker symbol "GENB."
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.